The Use of Pulse Oximeter by Public & Healthcare Providers in the Community for Suspected and Confirmed COVID-19 Cases

  • Version
  • Download 1948
  • File Size 80.25 KB
  • File Count 1
  • Create Date 27 May 2021
  • Last Updated 27 May 2021

The Use of Pulse Oximeter by Public & Healthcare Providers in the Community for Suspected and Confirmed COVID-19 Cases

Objectives
This is a document to support the use of pulse oximeter for assessment of suspected and confirmed cases of Covid-19 in the community.
Rationale
It is a well-known fact that Covid-19 can present as “happy hypoxia” with minimum symptoms of severe respiratory distress despite significant low oxygen levels in the blood. The use of pulse oximeter for clinical assessment significantly augments decision making, save lives and provide high quality care. It allows for early detection of patients with hypoxia requiring either close monitoring in the community or timely referral for hospital care.
How to use a pulse oximeter
Follow these instructions to make sure the pulse oximeter gives an accurate reading:
• Remove any nail polish or false nails and warm the hand if cold.
• Ensure patient has been resting for at least five minutes before taking the measurement.
• Rest the hand on the chest at heart level and hold still.
• Switch the pulse oximeter on and place it on the finger. It works best on the middle or index finger. It should not be used on the ear.
• The reading takes time to steady. Keep the pulse oximeter in place for at least a minute, or longer if the reading keeps changing.
• Record the highest result once the reading has not changed for five seconds.
• Be careful to identify which reading is the heart rate and which is the blood oxygen level
• Wash your hands carefully after the procedure, and if being used on different patients then ensure that it is cleaned after each usage.

Attached Files

FileAction
Guidance on Pulse Oximeter use for COVID-19Download

This slide deck, presented at the Developing Countries Vaccine Manufacturers Network International Annual General Meeting in October 2024, describes updated results from a study to assess the current and planned state of vaccine manufacturing in Africa and provides insights into what’s needed to develop a robust and sustainable vaccine manufacturing ecosystem.

We surveyed African vaccine manufacturers to better understand their current manufacturing capacity and capabilities, the progress they’ve made since 2023, and their future outlooks. This information can help stakeholders and funders better coordinate and prioritize actions to build a successful African vaccine manufacturing ecosystem.

Corporate author(s): Africa Centres for Disease Control and Prevention (Africa CDC); Clinton Health Access Initiative (CHAI); PATH

Publication date: October 2024

Download Files
FileAction
African Vaccine Manufacturing Mapping | Supply and Demand LandscapeDownload